Lecanemab Alzheimer’s Treatment Set for FDA Approval
Medical teams are preparing to begin offering Lecanemab with FDA approval expected soon. Read about the benefits along with some of the potential issues here.
Related Articles
Exciting Breakthrough in Dementia Research at Macquarie University
Neuroscientists at Macquarie University in Australia have made a groundbreaking discovery in the fight against neurodegenerative diseases. They have developed a single-dose genetic medicine called…
Encouraging results from a study on a subcutaneous formulation of Leqembi
Shortly after the FDA approved the much-anticipated Alzheimer’s drug Leqembi as an intravenous infusion, Eisai announced positive results from a study examining a subcutaneous formulation…
Celebrities Shining a Light on Lesser Known Dementias
Creating awareness about dementias other than Alzheimer’sby Gary Skole While Alzheimer’s disease is the most common type of dementia, comprising up to 80% of cases,…
New study shows Alzheimer’s Disease may begin in 20’s
“The real problem with Early onset Alzheimer’s is it can be missed completely. The diagnosis is very difficult because in younger people you don’t expect…
Donanemab: The Breakthrough Drug Ushering a New Era in Alzheimer’s Treatment
A new Alzheimer’s drug, Donanemab shows a 35% slowdown in cognitive decline.
Responses